![The breaking news round-up: Decagear launches today, Pimax announces new headsets, and more! [APRIL FOOL’S]](https://i0.wp.com/skarredghost.com/wp-content/uploads/2025/03/lawk_glasses_handson.jpg?fit=1366%2C1025&ssl=1)
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
An Illinois jury ruled in favor of Boehringer Ingelheim in Zantac litigation bro...
Johnson & Johnson is suing Samsung Bioepis for allegedly breaching the terms of ...
Duality Biologics, an ADC startup that's attracted multiple biopharma partnershi...
Thermo Fisher Scientific is spending $4.1 billion in cash to acquire US healthca...
Several contract research, development and manufacturing organizations based in ...
Eli Lilly is buying Organovo’s farnesoid X receptor (FXR) agonist program, which...
Plus, news about BioCity Biopharma, Kiniksa, Inceptor Bio, Ryvu Therapeutics, Re...
We’re about to see what happens when compounding goes from filling a gap left by...
Hims & Hers expects revenue from its weight loss business to soar in 2025, even ...
For the fourth year running, Endpoints News will highlight the biotech leaders w...
Takeda must have liked what it got from the chemoproteomics work out of BridGene...
Alnylam may be gearing up for its biggest commercial launch yet in its nearly 23...
It’s no great surprise that RA Capital weighed in — again — as the most ubiquito...
Eli Lilly will start selling additional single-dose vials of its weight loss dru...
An unusual legal battle over a biotech startup's IPO plans escalated to another ...
Some of the more than 200 staffers laid off at the FDA's Center for Devices and ...